HomeCompareCSPCY vs STAG

CSPCY vs STAG: Dividend Comparison 2026

CSPCY yields 2.60% · STAG yields 3.99%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSPCY wins by $918.6K in total portfolio value
10 years
CSPCY
CSPCY
● Live price
2.60%
Share price
$4.61
Annual div
$0.12
5Y div CAGR
65.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$938.0K
Annual income
$630,692.19
Full CSPCY calculator →
STAG
STAG Industrial Inc.
● Live price
3.99%
Share price
$36.80
Annual div
$1.47
5Y div CAGR
1%
Payout ratio
72%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.4K
Annual income
$606.20
Full STAG calculator →

Portfolio growth — CSPCY vs STAG

📍 CSPCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSPCYSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSPCY + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSPCY pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSPCY
Annual income on $10K today (after 15% tax)
$221.26/yr
After 10yr DRIP, annual income (after tax)
$536,088.36/yr
STAG
Annual income on $10K today (after 15% tax)
$339.54/yr
After 10yr DRIP, annual income (after tax)
$515.27/yr
At 15% tax rate, CSPCY beats the other by $535,573.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSPCY + STAG for your $10,000?

CSPCY: 50%STAG: 50%
100% STAG50/50100% CSPCY
Portfolio after 10yr
$478.7K
Annual income
$315,649.20/yr
Blended yield
65.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

CSPCY
No analyst data
Altman Z
6.5
Piotroski
5/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+22.3% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSPCY buys
0
STAG buys
0
No recent congressional trades found for CSPCY or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSPCYSTAG
Forward yield2.60%3.99%
Annual dividend / share$0.12$1.47
Payout ratio50%72%
1-year div growth0%0.5%
5-year div CAGR65.6%1%
Portfolio after 10y$938.0K$19.4K
Annual income after 10y$630,692.19$606.20
Total dividends collected$886.9K$5.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CSPCY vs STAG ($10,000, DRIP)

YearCSPCY PortfolioCSPCY Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$11,131$431.06$10,723$403.45+$408.00CSPCY
2$12,653$742.60$11,490$423.42+$1.2KCSPCY
3$14,845$1,306.42$12,302$444.01+$2.5KCSPCY
4$18,256$2,372.19$13,161$465.24+$5.1KCSPCY
5$24,049$4,515.02$14,069$487.12+$10.0KCSPCY
6$34,938$9,205.02$15,029$509.63+$19.9KCSPCY
7$58,080$20,696.38$16,042$532.80+$42.0KCSPCY
8$115,393$53,247.73$17,112$556.61+$98.3KCSPCY
9$287,202$163,731.68$18,241$581.08+$269.0KCSPCY
10$937,999$630,692.19$19,431$606.20+$918.6KCSPCY

CSPCY vs STAG: Complete Analysis 2026

CSPCYStock

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.

Full CSPCY Calculator →

STAGREIT

STAG Industrial is a single-tenant industrial REIT paying monthly dividends. Its portfolio of 500+ warehouses and distribution centers benefits from e-commerce growth. Amazon is its largest tenant. Monthly income frequency makes it attractive for investors who prefer regular cash flow over quarterly payments.

Full STAG Calculator →
📬

Get this CSPCY vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSPCY vs SCHDCSPCY vs JEPICSPCY vs OCSPCY vs KOCSPCY vs MAINCSPCY vs PLDCSPCY vs EQRCSPCY vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.